Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Canaccord Genuity analyst David Hynes maintains Definitive Healthcare (NASDAQ:DH) with a Hold and lowers the price target fr...
Definitive Healthcare (NASDAQ:DH) raises FY2025 Adj EPS guidance from $0.22-$0.23 to $0.23-$0.24 vs $0.23 analyst estimate. Rai...
Definitive Healthcare (NASDAQ:DH) is looking for Q4 Adj EPS of $0.05-$0.06 vs $0.06 analyst estimate. sees sales of $59.000 mil...
Definitive Healthcare (NASDAQ:DH) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $...
Stifel analyst David Grossman maintains Definitive Healthcare (NASDAQ:DH) with a Buy and raises the price target from $5 to $6.
Definitive Healthcare (NASDAQ:DH) raises FY2025 Adj EPS guidance from $0.20-$0.23 to $0.22-$0.23 vs $0.21 analyst estimate. Rai...
Definitive Healthcare (NASDAQ:DH) is looking for Q3 Adj EPS of $0.05-$0.06 vs $0.06 analyst estimate. sees sales of $59.000 mil...
